The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor
Open accessAbstract
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Here, we provide evidence that the Forkhead Box (Fox) m1b (Foxm1b or Foxm1) transcription factor is essential for the development of HCC. Conditionally deleted Foxm1b mouse hepatocytes fail to proliferate and are highly resistant to developing HCC in response to a Diethylnitrosamine (DEN)/Phenobarbital (PB) liver tumor-induction protocol. The mechanism of resistance to HCC development is associated with nuclear accumulation of the cell cycle inhibitor p27 Kip1 protein and reduced expression of the Cdk1-activator Cdc25B phosphatase. We showed that the Foxm1b transcription factor is a novel inhibitory target of the p19 ARF tumor suppressor. Furthermore, we demonstrated that conditional overexpression of Foxm1b protein in osteosarcoma U2OS cells greatly enhances anchorage-independent growth of cell colonies on soft agar. A p19 ARF 26–44 peptide containing nine D-Arg to enhance cellular uptake of the peptide was sufficient to significantly reduce both Foxm1b transcriptional activity and Foxm1b-induced growth of U2OS cell colonies on soft agar. These results suggest that this (D-Arg)9-p19 ARF 26–44 peptide is a potential therapeutic inhibitor of Foxm1b function during cellular transformation. Our studies demonstrate that the Foxm1b transcription factor is required for proliferative expansion during tumor progression and constitutes a potential new target for therapy of human HCC tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690 · cited 6×
“Loss of p19 function is a critical event for tumor promotion, as evidenced by extinguished expression of the p19 protein in a variety of tumors through DNA methylation and silencing of the p19 promoter region (Sherr and McCormick 2002).”
BackgroundResultInfluentialWender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13003 · Cited by 1,615
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · cited 1×
“The p19ARF (p19) protein targets the p53 negative regulator Mdm2 to the nucleolus, thus stabilizing the p53 transcription factor, which regulates genes mediating G1 cell cycle arrest and/or apoptosis (Palmero et al. 1998; Pomerantz et al. 1998; Weber et al. 1999).”
BackgroundOuelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5
Clark, K. L., Halay, E. D., Lai, E., & Burley, S. K. (1993) · Nature · doi:10.1038/364412a0 · Cited by 1,274
Unified nomenclature for the winged helix/forkhead transcription factors
Kaestner, K. H., Knöchel, W., & Martínez, D. E. (2000) · Genes & Development · doi:10.1101/gad.14.2.142 · Cited by 1,158
The Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153 · cited 3×
“It is well established that Cdk2 activity in complex with either Cyclin E or Cyclin A cooperates with Cyclin D-Cdk4/6 to phosphorylate the Retinoblastoma (RB) protein, which results in release of bound E2F transcription factor, allowing stimulation of genes required for S phase (Harbour and Dean 2000; Ishida et al. 20…”
BackgroundPKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M. K., Han, K., Lee, J.-H., Ciarallo, S., Catzavelos, C., Beniston, R., et al. (2002) · Nature Medicine · doi:10.1038/nm761 · Cited by 948
Nucleolar Arf sequesters Mdm2 and activates p53
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940
Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., & Roberts, J. M. (1997) · Nature Medicine · doi:10.1038/nm0297-222 · Cited by 901
Shin, I., Yakes, F. M., Rojo, F., Shin, N.-Y., Bakin, A. V., Baselga, J., & Arteaga, C. L. (2002) · Nature Medicine · doi:10.1038/nm759 · Cited by 790
Tumor surveillance via the ARF–p53 pathway
Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 717
Viglietto, G., Motti, M. L., Bruni, P., Melillo, R. M., D'Alessio, A., Califano, D., Vinci, F., Chiappetta, G., Tsichlis, P., Bellacosa, A., et al. (2002) · Nature Medicine · doi:10.1038/nm762 · Cited by 701
Bax suppresses tumorigenesis and stimulates apoptosis in vivo
Yin, C., Knudson, C. M., Korsmeyer, S. J., & Dyke, T. V. (1997) · Nature · doi:10.1038/385637a0 · Cited by 654
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615
Ishida, S., Huang, E., Zuzan, H., Spang, R., Leone, G., West, M., & Nevins, J. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4684-4699.2001 · Cited by 596
Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., & Nakamura, Y. (2001) · PubMed · Cited by 546
Molecular viral oncology of hepatocellular carcinoma
Block, T. M., Mehta, A. S., Fimmel, C. J., & Jordan, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206557 · Cited by 495
Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J.-P., Rath, M., & Wagner, E. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00042-4 · Cited by 474
Cell cycle regulation by the Cdc25 phosphatase family
Nilsson, I., & Hoffmann, I. (2000) · Progress in Cell Cycle Research · doi:10.1007/978-1-4615-4253-7_10 · Cited by 450
Control of Cell Cycle Exit and Entry by Protein Kinase B-Regulated Forkhead Transcription Factors
Kops, G. J. P. L., Medema, R. H., Glassford, J., Essers, M. A. G., Dijkers, P. F., Coffer, P. J., Lam, E. W.-F., & Burgering, B. M. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2025-2036.2002 · Cited by 442
Transcription Factors in Liver Development, Differentiation, and Regeneration
Costa, R. H., Kalinichenko, V. V., Holterman, A.-X. L., & Wang, X. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.034 · Cited by 409
Self-citationTAT-Mediated Protein Transduction into Mammalian Cells
Becker-Hapak, M., McAllister, S. S., & Dowdy, S. F. (2001) · Methods · doi:10.1006/meth.2001.1186 · Cited by 384
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma
Barr, F. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204599 · Cited by 383
DNA excision in liver by an albumin-Cre transgene occurs progressively with age
Postic, C., & Magnuson, M. A. (2000) · genesis · doi:10.1002/(sici)1526-968x(200002)26:2<149::aid-gene16>3.0.co;2-v · Cited by 369
Ye, H., Kelly, T. F., Samadani, U., Lim, L., Rubio, S., Overdier, D. G., Roebuck, K. A., & Costa, R. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1626 · Cited by 359
Self-citationFOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh, M., Wong, S.-T., Neill, G. W., Ghali, L. R., Philpott, M. P., & Quinn, A. (2002) · PubMed · Cited by 356
(1999) · PubMed · Cited by 338
Wang, X., Kiyokawa, H., Dennewitz, M. B., & Costa, R. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252570299 · Cited by 327
Self-citationvan den Boom, J., Wolter, M., Kuick, R., Misek, D. E., Youkilis, A. S., Wechsler, D. S., Sommer, C., Reifenberger, G., & Hanash, S. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63463-3 · Cited by 307
Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex
Weber, J. D., Kuo, M.-L., Bothner, B., DiGiammarino, E. L., Kriwacki, R. W., Roussel, M. F., & Sherr, C. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2517-2528.2000 · Cited by 275
Major, M. L., Lepe, R., & Costa, R. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2649-2661.2004 · Cited by 266
Self-citationYao, F., Svensjö, T., Winkler, T., Lu, M., Eriksson, C., & Eriksson, E. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.13-1939 · Cited by 256
Oncogene-induced liver neoplasia in transgenic mice.
Sandgren, E. P., Quaife, C. J., Pinkert, C. A., Palmiter, R. D., & Brinster, R. L. (1989) · PubMed · Cited by 248
Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15.
Sebastian, B., Kakizuka, A., & Hunter, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3521 · Cited by 242
The winged-helix transcription factor Trident is expressed in cycling cells
Korver, W., Roose, J., & Clevers, H. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.9.1715 · Cited by 238
Wu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y., & Van Dyke, T. (1996) · Genes & Development · doi:10.1101/gad.10.3.245 · Cited by 234
Wang, X., Quail, E., Hung, N.-J., Tan, Y., Ye, H., & Costa, R. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201360898 · Cited by 208
Self-citationPan, H., Yin, C., Dyson, N. J., Harlow, E., Yamasaki, L., & Van Dyke, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80273-7 · Cited by 197
Ye, H., Holterman, A. X., Yoo, K. W., Franks, R. R., & Costa, R. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8570 · Cited by 173
Self-citationp19ARF targets certain E2F species for degradation
Martelli, F., Hamilton, T., Silver, D. P., Sharpless, N. E., Bardeesy, N., Rokas, M., DePinho, R. A., Livingston, D. M., & Grossman, S. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081061398 · Cited by 166
Wang, X., Krupczak-Hollis, K., Tan, Y., Dennewitz, M. B., Adami, G. R., & Costa, R. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207510200 · Cited by 154
Self-citationIn Vivo Amplification of the PAX3-FKHR and PAX7-FKHR Fusion Genes in Alveolar Rhabdomyosarcoma
Barr, F. G., Nauta, L. E., Davis, R. J., Schäfer, B. W., Nycum, L. M., & Biegel, J. A. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.15 · Cited by 151
Korver, W., Schilham, M. W., Moerer, P., van den Hoff, M. J. B., Dam, K. V., Lamers, W. H., Medema, R. H., & Clevers, H. C. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00563-5 · Cited by 148
Sandgren, E. P., Luetteke, N., Qiu, T. H., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.320-330.1993 · Cited by 135
Molecular Analysis of a Novel Winged Helix Protein, WIN
Yao, K., Mi, S., Lu, Z., & Wong, G. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.19827 · Cited by 133
The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture.
Scheidler, S., Fredericks, W. J., Rauscher, F. J., Barr, F. G., & Vogt, P. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9805 · Cited by 130
Conzen, S. D., Gottlob, K., Kandel, E., Khanduri, P., Wagner, A. J., O'Leary, M., & Hay, N. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6008-6018.2000 · Cited by 120
p27 KIP1 Blocks Cyclin E-Dependent Transactivation of Cyclin A Gene Expression
Zerfass, K., Schulze, A., Zwerschke, W., Vogt, B., Helin, K., Bartek, J., Henglein, B., & Jansen‐Dürr, P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.407 · Cited by 119
Li, J., & Vogt, P. K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4490 · Cited by 117
Growth hormone stimulates proliferation of old-aged regenerating liver through forkhead box m1b
Krupczak-Hollis, K. (2003) · Hepatology · doi:10.1053/jhep.2003.08052 · Cited by 115 · cited 3×
“In addition to re-establishing expression of cell cycle regulatory genes, levels of the Cdk inhibitor p27kip1 protein were diminished when Foxm1b expression was restored in old-aged regenerating liver (Wang et al. 2002b; Krupczak-Hollis et al. 2003).”
BackgroundKalinichenko, V. V., Gusarova, G. A., Tan, Y., Wang, I., Major, M. L., Wang, X., Yoder, H. M., & Costal, R. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305555200 · Cited by 111
Self-citationRausa, F. M., Tan, Y., Zhou, H., Yoo, K. W., Stolz, D. B., Watkins, S. C., Franks, R. R., Unterman, T. G., & Costa, R. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8264-8282.2000 · Cited by 109
Self-citationDeregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer
Alkarain, A., & Slingerland, J. M. (2003) · Breast Cancer Research · doi:10.1186/bcr722 · Cited by 108
Wang, X., Hung, N., & Costa, R. H. (2001) · Hepatology · doi:10.1053/jhep.2001.24666 · Cited by 87
Self-citationWu, J. C., Merlino, G. T., Cveklová, K., Mosinger, B. J., & Fausto, N. (1994) · PubMed · Cited by 85
Rausa, F. M., Tan, Y., & Costa, R. H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.437-449.2003 · Cited by 77
Self-citationFactor, V. M., Oliver, A. L., Panta, G. R., Thorgeirsson, S. S., Sonenshein, G. E., & Arsura, M. (2001) · Hepatology · doi:10.1053/jhep.2001.25270 · Cited by 75
Differential Regulation of E2F1, DP1, and the E2F1/DP1 Complex by ARF
Datta, A., Nag, A., & Raychaudhuri, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8398-8408.2002 · Cited by 72
Self-citationTreatment of hepatocellular carcinoma: is there an optimal strategy?
Varela, M., Sala, M., Llovet, J. M., & Bruix, J. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00123-8 · Cited by 69
Developmental changes in the methylation of the rat albumin and alpha‐fetoprotein genes.
Kunnath, L., & Locker, J. D. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01425.x · Cited by 57
Kalinina, O. A., Kalinin, S., Polack, E., Mikaelian, I., Panda, S., Costa, R. H., & Adami, G. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206640 · Cited by 55
Self-citationp21 Functions to Maintain Quiescence of p27-deficient Hepatocytes
Kwon, Y. H., Jovanović, A., Serfas, M. S., Kiyokawa, H., & Tyner, A. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203388200 · Cited by 48
Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli
Ledda-Columbano, G. M., Pibiri, M., Concas, D., Cossu, C., Tripodi, M., & Columbano, A. (2002) · Hepatology · doi:10.1053/jhep.2002.36159 · Cited by 45
Differential regulation of cyclin B1 RNA and protein expression during hepatocyte growth in vivo.
Trembley, J. H., Ebbert, J. O., Kren, B. T., & Steer, C. J. (1996) · PubMed · Cited by 38
Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
Sargent, L. M., Dragan, Y. P., Xu, Y., Sattler, G. L., Wiley, J. E., & Pitot, H. C. (1996) · PubMed · Cited by 35
Hatayama, I., Nishimura, S., Narita, T., & Sato, K. (1993) · Carcinogenesis · doi:10.1093/carcin/14.3.537 · Cited by 25
Cited by
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
The emerging roles of forkhead box (Fox) proteins in cancer
Myatt, S. S., & Lam, E. W. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2223 · Cited by 1,070
Basal cell carcinomas: attack of the hedgehog
Epstein, E. H. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2503 · Cited by 834
Metadata
- Authors
- Kalinichenko, V. V., Major, M. L., Wang, X., Petrovic, V., Kuechle, J., Yoder, H. M., Dennewitz, M. B., Shin, B., Datta, A., Raychaudhuri, P., & Costa, R. H.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-04-01
- Volume
- 18
- Issue
- 7
- Pages
- 830-850
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2158838322
- Cited by
- 356
- References
- 73
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.